Maria Meritxell Roca Mora: DOACs Show Promise Over VKAs in Kidney Transplant Recipients
Meta Analysis Academy shared on X:
”New Meta Master Publication Alert
A systematic review and Meta-Analysis of 5 studies (n=959 patients) compared direct-acting oral anticoagulants (DOACs) vs. vitamin K antagonists (VKAs) in kidney transplant recipients (KTRs).
Key findings:
- DOACs reduced major bleeding
- DOACs lowered mortality
- No significant difference in VTE risk, in graft failure and kidney function (eGFR)
Conclusion: DOACs may be an effective anticoagulation strategy in KTRs, offering reduced bleeding and mortality compared with VKAs, though evidence quality remains low-to-moderate.”
Read the full article here.
Article: Safety and efficacy of direct oral anticoagulants in kidney transplant recipients: A systematic review and meta-analysis
Authors: Maria Meritxell Roca Mora, Andre Milani Reis, Filipe Piazzi Tavares, Lídia Santos Oliveira, Amanda Godoi, Patricia Viana, Juliano Riella
Stay updates on the latest advances in the field of anticoagulation with Hemostasis Today.
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria